Vanguard Global Advisers’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$670K Buy
8,109
+106
+1% +$9.39K ﹤0.01% 1950
2026
Q2
$768K Sell
8,003
-459
-5% -$47.1K ﹤0.01% 1893
2026
Q1
$924K Buy
+8,462
New +$807K ﹤0.01% 1698

Other funds holding LMAT

Vanguard Global Advisers's LMAT Position: Q3 2026 in Review

Vanguard Global Advisers increased its LeMaitre Vascular (LMAT) stake by 1.3% in Q3 2026, buying an estimated $9.39K and bringing the position to 8,109 shares worth $670K. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

Vanguard Global Advisers first reported a position in LMAT in Q1 2026 and has held it in 3 quarters since. The position peaked at $924K in Q1 2026. 298 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Vanguard Global Advisers held 8,109 shares of LeMaitre Vascular worth $670K as of Q3 2026.
  • Vanguard Global Advisers bought 106 LeMaitre Vascular shares in Q3 2026, an estimated $9.39K.
  • LeMaitre Vascular made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1950 holding.
  • Vanguard Global Advisers first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's LeMaitre Vascular position peaked at $924K in Q1 2026.
  • 298 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.